Molecular Modeling Study of 2-Substituted Isoindoline Derivatives of a-Amino Acids as Inhibitors of Lipoxygenase by Docking Simulations

Authors

  • Teresa Mancilla Percino Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional
  • José Correa Basurto Instituto Politécnico Nacional
  • Karla S. Alavés Carbajal Instituto Politécnico Nacional
  • Nagchielli Valle-Sandoval Instituto Politécnico Nacional
  • José Trujillo Ferrara Instituto Politécnico Nacional

DOI:

https://doi.org/10.29356/jmcs.v53i1.1010

Keywords:

Lipoxygenase, Docking, Isoindolines, Antiinflamatory, Analgesic, a-Amino acids

Abstract

In this work two series of isoindolines 1(a-g) and 2(a-g) were evaluated as possible inhibitors of lipoxygenase (LOX) by docking studies, as well as for the antiinflammatories isoindolilamides 3-5 and ibuprofen 6, as part of a theoretical study to found dual LOX/ COX inhibitory activities. Therefore, dihydrodimethylbenzofurane 7, licofelone 8 and darbufelone 9 were also evaluated, which are wellknown as dual LOX/COX inhibitors and consequently, in this work they were used to identify their binding sites on the LOX and compared with those obtained from 1(a-g), 2(a-g) and 3 to 6 under study. Analysis of the results showed that all compounds under study could inhibit to the LOX, since they are binding in the same or close to the region as the compounds 7-9 taken as references. Several interactions of heteroatom of all compounds with the amino acid residues of binding sites of LOX were determined. The DG values were obtained for all the complexes (LOX-compound), among all the complexes, LOX-8 (-12.76 kcal/mol) resulted to be the most stable; and from the compounds under study, LOX-1f (-8.97 kcal/mol) resulted to be more stable than the other compounds tested. Whereas, theoretical dissociation constant values Kd (mM) were obtained. Among all compounds, 8 (0.000433 mM) showed more affinity to LOX; while from compounds under study, 1f (0.266 mM) exhibited more affinity to LOX. These results also show that compounds 1(a-g) and 2(a-g), and 3-6 could have a dual LOX/COX/ inhibition, as have been shown for 7-9 and from their similar docking study within the COX-1 and COX-2 previously reported.

Downloads

Download data is not yet available.

Author Biographies

Teresa Mancilla Percino, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional

Departamento de Química

José Correa Basurto, Instituto Politécnico Nacional

Escuela Superior de Medicina, Departamento de Bioquímica, Departamento de Farmacología

Karla S. Alavés Carbajal, Instituto Politécnico Nacional

Escuela Superior de Medicina

Nagchielli Valle-Sandoval, Instituto Politécnico Nacional

Escuela Superior de Medicina

José Trujillo Ferrara, Instituto Politécnico Nacional

Escuela Superior de Medicina, Departamento de Bioquímica, Departamento de Farmacología

References

1. Morgan, Jr. G. E.; Mikhail, M. S.; Murray M. J. Anestesiología Clínica, 3ed. México, Manual Moderno, 2003, 325-338.
2. Masahide, M.; Rikio, Y. Drug Target Insights. 2008, 3, 137-151.
3. Vane, J. R.; Botting, R. M. Inflamm Res. 1998, 47(suppl. 2), S78S87.
4. Brater, D. C.; Harris, C.; Redfern, J. S.; Gertz, B. J. Am. J. Nephrol. 2001, 21, 1-15.
5. Vane, J. R.; Bakhle, Y. S.; Botting, R. M. Annu. Rev. Pharmacol. Toxicol. 1998, 38, 97-120.
6. Parente, L. J. Rheumatol. 2001, 28, 2375-2382.
7. McAdam, B. F.; Castella-Lawson, F.; Mardini, I. A.; Kapoor, S., Lawson, J. A.; FitzGerald, G. A. Proc. Natl. Acad. Sci. USA. 1999, 96, 272-277.
8. Geronikaki, A. A.; Lagunin, A. A.; Hadjipavlou-Lithina, D. I.; Eleftheriou. P.T., Filimonov, D. A., Poroikov, V. V., Alam, I. Saxena, A. K. J. Med. Chem. 2008, 51, 1601-1609.
9. Charlier, C.; Michaux, C. Eur. J. Med. Chem. 2003, 38, 645-659.
10. Gillmor, S. A.; Villaseñor, A.; Fletterick, R.; Sigal, E., Browner, M. F. Nat. Str. Biol. 1997, 4, 1003-1009.
11. Wenzig, E. M.; Oleszek, W.; Stochmal, A.; Kunert, O.; Bauer R. J. Agric. Food. Chem. 2008, 56, 8885-8890.
12. Singh, S.; Khajuria, A.; Taneja, S. C.; Johri, R. K.; Singh, J.; Qazi, G. N. Phytomedicine. 2008, 15, 400-407.
13. Hoshino, T.; Tabuchi, K.; Hirose, Y.; Uemaetomari, I.; Murashita, H.; Tobita, T.; Hara, A. Tohoku J. Exp. Med. 2008, 216, 53-59.
14. Pirillo, A.; Uboldi, P.; Bolego, C.; Hartmut, K.; Catapano, A. L. The Journal of Immonology, 2008, 181, 2821-2830.
15. Yoo, Hyun.; Jeon, B.; Jeon, M-S.; Lee, H.; Kim, T-Y. FEBS Letters 2008, 582, 3249-3253.
16. Mei, G.; Venere, A.; Nicolai, E.; Angelucci, C. B.; Ivanov, I.; Sabatucci, A.; Dainese, E.; Kuhn, H.; Maccarrone, M. Biochemistry 2008, 47, 9234-9242.
17. Claesson, H-E.; Griffiths, W. J.; Brunnström, Ä.; Shain, F.; Andersson, E.; Feltenmark, S.; Johnson, H. A.; Porwit, A.; Sjöberg, J., Björkholm, M. FEBS Journal, 2008, 275, 4222-4234.
18. Maier, T. J.; Tausch, L.; Hoernig, M.; Coste, O.; Schmidt, R.; Angioni, C., Metzner, J., Groesch, S., Pergola, C., Steinhilber, D., Werz, O.; Geisslinger, G. Biochem. Pharmacol. 2008, 76, 862-872.
19. Yong Hwan, Ch.; Hyun, L.; Moon Young, H.; Dae Young, D.; Hyun Pyo, K. J. Med. Food. 2008, 11, 539-543.
20. Celotti, F.; Laufer, S. Pharmacol. Res. 2001, 43, 429-436.
21. Chowdhury, M. A.; Abdellatif, K. R. A.; Dong, Y., Das, D., Suresh, M. R.; Knaus, E. E. Bioorg. Med. Chem. Lett. 2008, 18, 6138-6141.
22. Zhang, B.; Wang, C. L.; Zhao, W. H.; Lu, M.; Wang, Ch.Y.; Zhong, W. X., Zhou, W. Y., Yu, W. S., Zhang, Y., Li. World J. Gastroenterol. 2008,14, 2494-2500.
23. Horizoe, T.; Nagakura, N.; Chiba, K.; Shirota, H.; Shinoda, M., Numata, H.; Kobayashi, S.; Abe, C. Inflamm. Res. 1999, 48, 432436.
24. Bannwarth, B. Fundam. Clin. Pharmacol. 2004, 18, 125-130.
25. Rotondo, S.; Krauze-Brzósko, K.; Manarini, S.; Evangelista, V.; Cerletti, C. Eur. J. Pharmacol. 2004, 488, 79-83.
26. Rao, P. N. P.; Chen, Q. H.; Knaus, E. E. J. Med. Chem. 2006, 49, 1668-1683.
27. Janusz, J. M.; Young, P. A.; Ridgeway, J. M.; Scherz, M. W.; Enzweiler, K.; Wu, L. I.; Gan, L.; Darolia, R.; Matthews, R. S.; Hennes, D.; Kellstein, D. E.; Green, S. A.; Tulich, J. L.; RosarioJansen, T.; Magrisso, I. J.; Wehmeyer, K. R.; Kuhlenbeck, D. L.; Eichhold, T. H.; Dobson, R. L. M.; Sirko, S. P.; Farmer, R. W. J. Med. Chem. 1998, 41, 1112-1123.
28. Alvaro-Gracia, J. M. Rheumatology 2004, 43(Suppl. 1), i21-i25.
29. Berger, D., Citarella, R., Dutia, M., Grenberger, L. Hallet, W., Poweel, D. J. Med. Chem. 1999, 42, 2145-2161.
30. Cignarella, G.; Sanna, P. J. Med. Chem. 1981, 24, 1003-1010.
31. Sanna, P.; Cignarella, G.; Ananiaa, V.; Siri, R.M. S.; Desole, M. S. Farmaco Ed. Sci. 1985, 40, 777-785.
32. Heidenbluth, K.; Franke, J.; Helga, F.; Toenjes, H.; Schmidt, J. Fr. M. 7732 (CI. A 61K, C 07d), 09 Mar 1970, Appl. 164, 252,27 Aug 1968, 9 pp; Chem. Abstr. 1972, 77, 114241z.
33. Chimenti, F.; Vomero, S.; Farmaco, Ed. Sci. 1975, 30, 884-890, Chem. Abstr. 1976, 84, 43756c.
34. Casagrande, C.; Galli, A.; Ferrini, R.; Miragoli, G. Farmaco [Sci], 1972, 27, 445-470.
35. Carneym, W. J. R.; De Stevens, G., (CIBA LTD.) Ger. Offen. 2.034,240 (CI.CO7d), 28 Jan 1971, US Appl. 18 Jul 1969-25 May 1970, 106 pp. ; Addn. to Ger offen. 1, 913,743 (CA72:1005349q); Chem. Abstr., 1971, 74, 125471.
36. Shuhmann, A.; Tonjes, H.; Schmidt, J. Brit. 989,917 (CI.CO7d), April 22, 1965, Appl. May 15, 1963, 5 pp; Chem. Abstr., 1965, 63, 4261.
37. Dresden, V. A. Belg. 634.852. Oct. 31, 1963, Appl. Jul 11, 1963, 9, 9 pp., Chem. Abstr., 1965, 63, 4261.
38. Mancilla, T.; Carrillo, L.; Zamudio-Rivera, L. S.; Beltrán, H. I., Farfán, N. Org, Prep. Proc. Int. 2001, 33, 341-349.
39. Mancilla, T.; Correa-Basurto, J.; Alavés Carbajal, K. S.; Sánchez Escalante, E. T. J.; Trujillo Ferrara, J. J. Mex. Chem. Soc. 2007, 51, 96-102.
40. Mancilla, T.; Talamás, P.; Díaz, G. J. A.; Correa-Basurto, J.; Alavés Carbajal K. S.; Valle Sandoval, N. Trujillo Ferrara, J. 7th Pan American Regional Symposium. Facultad de Farmacia de la UAEM, México. Cuernavaca, Mor. 8-12, septiembre, 2008.
41. Enzymes, A Practical Introduction to Structure, Mechanism, and data Analysis, Copeland, R. A. Second Edition, 2000, 11-41, Wiley-VCH.
42. ISIS/Draw, MDL Information System, 14600 Catalina Street, San Leandro, CA 94677, USA. The program (Editions of 2.5 and 2.3) is available at the MDL at hhh://www.mdli.com/
43. WebLab Viewer, available at http://www.liv.ac.uk/ctichem/ 16weblab.html
44. Flükiger, P. F., Development of the Molecular Graphics Package MOLEKEL and its Application to Selected Problems in Organic and Organometallic Chemistry, Thèse No 2561, Département de Chimie Physique, Université de Genève, Genève, 1992.
45. Frisch, M. J.; Trucks, G. W.; Schlegel, H.B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, Jr. J. A.; Stratmann, R. E.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Peterson, G. A.; Ayala, P.Y.; Cui Q.; Morokuma, K.; Malick, D. K.; Rabuck,
A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz, J. V.; Baboul, A. G.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I., Gomperts, R., Martin, R.L., Fox, D. J., Keith, T.; Al-Laham, M. A.; Peng, C.Y.; Nanayakkara, A.; Challacombe, M., Gill P. M. W., Johnson, B., Chen, W., Wong, M. W., Andres, J.L.; Gonzalez, C.; Head-Gordon, M.; Replogle E. S.; Pople, J. A.; Gaussian 98, Revision A.9, Gaussian, Inc., Pittsburgh, PA 1998.
46. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W.E.; Belew, R.K.; Olson, A. J. J. Comp. Chem. 1998, 19, 16391662.
47. Goodford, P. J. J. Med. Chem. 1985, 28, 849-857.
48. Humphrey, W.; Dalke, A.; Schulten K. J. Mol. Graph. 1996, 14, 33-38.

Downloads

Published

2019-06-24

Issue

Section

Regular Articles

Most read articles by the same author(s)